Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment
Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
A multi-center, open-label, extended treatment, clinical trial examining the safety of
administering multiple does of panitumumab by intravenous (i.v.) infusion to patients who
have previously received panitumumab and benefited from treatment